This invention pertains to implantable medical devices such as cardiac pacemakers and implantable cardioverter/defibrillators. In particular, the invention relates to a system and method for implementing telemetry in such devices.
Implantable medical devices, including cardiac rhythm management devices such as pacemakers and implantable cardioverter/defibrillators, typically have the capability to communicate data with a device called an external programmer via a radio-frequency telemetry link. One use of such an external programmer is to program the operating parameters of an implanted medical device. For example, the pacing mode and other operating characteristics of a pacemaker are typically modified after implantation in this manner. Modern implantable devices also include the capability for bidirectional communication so that information can be transmitted to the programmer from the implanted device. Among the data that may typically be telemetered from an implantable device are various operating parameters and physiological data, the latter either collected in real-time or stored from previous monitoring operations.
Telemetry systems for implantable medical devices utilise radio-frequency (RF) energy to enable bidirectional communication between the implantable device and an external programmer. An exemplary telemetry system for an external programmer and a cardiac pacemaker is described in U.S. Pat. No. 4,562,841, issued to Brockway et al. and assigned to Cardiac Pacemakers, Inc., the disclosure of which is incorporated herein by reference. A radio-frequency carrier is modulated with digital information, typically by amplitude shift keying where the presence or absence of pulses in the signal constitute binary symbols or bits. The external programmer transmits and receives the radio signal with an antenna incorporated into a wand that can be positioned in proximity to the implanted device. The implantable device also generates and receives radio signals by means of an antenna, typically formed by a wire coil wrapped around the periphery of the inside of the device casing. Most conventional radio-frequency telemetry systems used for implantable medical devices such as cardiac pacemakers utilize inductive coupling between the antennas of the implantable device and an external programmer in order to transmit and receive signals. Because the induction field produced by a transmitting antenna falls off rapidly with distance, such systems require close proximity between the implantable device and a wand antenna of the external programmer in order to work properly, usually on the order of a few inches. This requirement is an inconvenience for a clinician and limits the situations in which telemetry can take place.
Wireless radio-frequency communication over greater distances requires the use of far-field telemetry. Communication using far-field radiation can take place over much greater distances, which makes it more convenient to use an external programmer. Also, the increased communication range makes possible other applications of the telemetry system such as remote monitoring of patients and communication with other types of external devices such as network access points. In order for a substantial portion of the energy delivered to an antenna to be emitted as far-field radiation, the wavelength of the driving signal should not be very much larger than the length of the antenna. Far-field radio-frequency communications with an antenna of a size suitable for use in an implantable device therefore requires a carrier in the frequency range of between a few hundred MHz to a few GHz. Active transmitters and receivers for this frequency range require special components (typically including SiGe or GaAs semiconductor devices) that consume a significant amount of power (typically tens of milliwatts). Implantable medical devices, however, are powered by a battery contained within the housing of the device that can only supply a limited amount of continuous power before it fails. When the battery fails in an implantable device, it must be replaced which necessitates a re-implantation procedure. Power conservation is thus an important design objective in wireless telemetry systems for implantable medical devices.
The present invention relates to a telemetry system for enabling radio-frequency (RF) communications between an implantable medical device and an external device in a manner which reduces the power requirements of the implantable device. In accordance with the invention, the external device is programmed to transmit a data segment containing a repeating sequence of special wakeup characters in order to establish a communications session with the implantable device. The implantable device is programmed to power up its transmitter and receiver for a specified time window at periodic intervals defined by the wakeup timer and wait for receipt of one of the special wakeup characters transmitted by the external device. The implantable device maintains its transmitter and receiver in a powered-up state upon receipt of a special character and for as long as consecutive special wakeup characters continue to be received, to transmit an acknowledge signal to the external device upon receipt of at least one character other than a special wakeup character, and then to wait a specified period of time for a response from the external device. The external device and the implantable device then attempt to establish a communications session when a response to the acknowledge signal is received by the implantable device.
The present invention is a system and method for providing far-field telemetry between an implantable medical device and an external device in which power consumption by the implantable device is lessened by managing the duty cycle of the transmitting and receiving components. Long-range telemetry circuitry (i.e., the transmitter and receiver) typically requires power on the order of tens of milliwatts in order to operate. Implantable cardiac devices in use today, on the other hand, are usually designed to operate with average power in the microwatt range. This means that the telemetry circuitry must be duty cycled down in order to meet the power budget of such devices. Previous examples of duty cycling for implantable devices are described in U.S. Pat. No. 5,342,408 and U.S. patent application Ser. No. 10/025,223, entitled “A TELEMETRY DUTY CYCLE MANAGEMENT SYSTEM FOR AN IMPLANTABLE MEDICAL DEVICE”, presently assigned to Cardiac Pacemakers, Inc., and hereby incorporated by reference.
The telemetry circuitry of an implantable device can either be powered up or down, referred to as awake and sleep states, respectively. Duty cycling of the implantable device's telemetry circuitry can be implemented by a wakeup timer which defines periodic wakeup intervals at which the implantable device powers up its circuitry and listens for a transmission from an external device for a specified period of time, referred to as a wakeup window. Upon acknowledging the transmission from the external device, a communications session can be established by a handshaking protocol, and data can then be transferred between the devices. In order to minimize power consumption, it is desirable for the circuitry of the implantable device to be powered up for as short a time as possible at each wakeup interval while still being able to reliably recognize session requests from the external device. If the implantable device recognizes a session request from the external device during its wakeup window, it remains awake long enough to establish a communications session with the external device; otherwise, the implantable device returns to a sleep state until the next wakeup interval occurs.
In accordance with the present invention, the external device is programmed to transmit a data frame containing a repeating sequence of special wakeup characters when it is desired to establish a communications session with the implantable device. The implantable device is programmed to power up its transmitter and receiver for a specified wakeup window at periodic intervals defined by its wakeup timer and wait for receipt of one of the special wakeup characters transmitted by the external device. The implantable device maintains its transmitter and receiver in a powered-up state upon receipt of a special character and for as long as consecutive special wakeup characters continue to be received, and transmits an acknowledge signal to the external device upon receipt of at least one character other than a special wakeup character. After transmitting the acknowledge signal, the implantable device then waits a specified period of time for a response from the external device. When a response to the acknowledge signal is received by the implantable device, the external device and the implantable device are programmed to establish a communications session by a handshaking protocol. During a communications session, the transmitter and receiver of the implantable device may then either be maintained in the powered-up state for the duration of the communications session or powered down at prescribed intervals according to a defined protocol.
As described in detail below, the wakeup scheme may be designed to work in the context of a medium access control (MAC) protocol by which network participants contend for access to the wireless medium. Also, in one embodiment, the implantable device and the external device communicate by a transmission code which provides a DC balanced data stream such as 8b/10b. Such bit balanced data streams are advantageous in communications. In order for the special wakeup character to be invariant, the special wakeup character may be selected as a bit balanced sequence which is not changed by the transmission code.
In another particular embodiment, the external device is a remote monitor (RM) which operates to periodically collect data from the implantable device. The remote monitor may thus include a wakeup timer and be programmed to transmit a plurality of special wakeup characters to the implantable device in an attempt to establish a communications session at periodic intervals as defined by its wakeup timer. After the implantable device is awoken by the special wakeup characters, a communications session is established in which the implantable device transmits whatever data it has to the RM. If the implantable device has no data to transmit, however, the communications session is terminated almost immediately after being established. Such empty communications sessions still impose an energy cost upon the implantable device, however, due to the time it takes for the implantable device to wake up, establish a communications session with the RM, indicate that there is nothing to download, and then terminate the session. The total duty cycle of the circuitry in the implantable device is thus a function of both its own wakeup interval and the intervals at which the RM attempts to wake up the implantable device. In order to lessen power consumption by the implantable device, therefore, it is desirable for the intervals at which the RM attempts to wake up the implantable device to be such that the number of empty communications sessions is minimized. The remote monitor may thus be further programmed to adjust the periodic intervals at which it transmits a plurality of special wakeup characters to the implantable device in accordance with when previous successful communications sessions have been established such that data was collected. In one particular embodiment, the remote monitor is programmed to establish a communications session and collect data from the implantable device on a daily basis and further programmed to adjust the periodic intervals at which it attempts to wake up the implantable device in accordance with the time of day at which past successful communications sessions were established. In order to be able to respond to an episode, the remote monitor may also be programmed to transmit a plurality of special wakeup characters to the implantable device for establishing a communications session when a user command is received via a user interface.
A long-range receiver 120a or 120b and a long-range transmitter 110a or 110b are interfaced to the microprocessor 102a or 102b in the implantable device and the external device, respectively. Also in each device, the transmitter and receiver are coupled to an antenna 101a or 101b through a transmit/receive switch 130a or 130b. The transmit/receive switches 130a and 130b are controlled by the microprocessor and either passes radio-frequency signals from the transmitter to the antenna or from the antenna to the receiver. To effect communications between the devices, a radio-frequency carrier signal modulated with digital data is transmitted wirelessly from one antenna to the other. A demodulator for extracting digital data from the carrier signal is incorporated into each receiver, and a modulator for modulating the carrier signal with digital data is incorporated into each transmitter. The interface to the controller for the transmitter and receiver in each device enables data transfer. The implantable device also incorporates a means by which the controller can power up or power down the receiver and/or transmitter in order to manage duty cycles in the manner described below. A wakeup timer 180 for defining the duty cycle is also shown for the implantable device, and this timer can either be implemented in code executed by the controller or can be discrete components.
A wireless telemetry system for implantable medical devices is generally a multiple access network in which a number of network participants share the available bandwidth of the wireless medium. A medium access control (MAC) protocol may be defined which allows each network participant to acquire exclusive access to the medium before transmitting data to an intended recipient. A collision is said to occur when two or more participants attempt to transmit at the same time. In certain networks, collisions may be detected by the sender listening to the medium when a transmission is initiated to determine if other network activity is present. If a collision is detected, the sender ceases transmitting and waits for a random or defined period before trying again. Most wireless transceivers operate in a half-duplex mode, however, and cannot simultaneously transmit and listen for ongoing network activity. MAC protocols for wireless networks therefore typically use out-of-band signaling or a handshaking protocol to minimize the probability of a collision occurring. In an example of the latter type of protocol, a four-way RTS-CTS-DS-ACK exchange as illustrated by
a. Exemplary wakeup scheme
A particular embodiment of the invention will now be described with reference to an external programmer or remote monitor (PRM/RM) and an implantable device (referred to as a pulse generator or PG). In this embodiment, the wakeup process works within the framework of a handshaking collision avoidance scheme as described above. In such a scheme, a network participant may transmit a so-called universal broadcast to all other participants in the network by transmitting an RTS-CTS-DS-ACK sequence. The PRM/RM transmits the RTS and CTS frames to cause other participants to defer their transmissions, transmits a data segment DS, and then transmits an ACK frame to release the medium. The wakeup process is illustrated by
In the wakeup scheme just described, a problem may arise if two PG's are in range of the PRM/RM when the wakeup sequence is transmitted. If both PG's wake up and respond to the wakeup sequence with an ACK frame, a collision will occur. In a further modification of the scheme, the PRM/RM may therefore be programmed to monitor the signal strength after transmission of the wakeup sequence during the expected ACK response time and proceed with the discovery process if there is found to be some activity.
An advantage of the wakeup scheme described above is that the PRM/RM is able to quickly establish a communications session with the PG on demand. The PG will be woken up within 20 seconds if the PG wakes up every 20 seconds and wakes up when a special character is being transmitted. (The probability that the PG will be awoken within that time increases with the length of the sequence of repeating special characters transmitted by the PRM/RM.) At the same time, the PG is subjected to a very low duty cycle which lessens the power requirements of operating a far-field telemetry system to acceptable levels. For example, an exemplary implantable cardiac rhythm management device may operate at an average current draw on the order of 22 microamps and is designed to last 6 years before a battery replacement is needed. This means that each 305 nanoamps of current draw costs the device one month in longevity. When the circuitry is powered up, its current draw is on the order of 4 milliamps. If the device wakes up every 20 seconds and remains powered up for 500 microseconds, the duty cycle is 1/40,000. The average current due to wake ups (but not, of course, including the current necessary for actually performing telemetry) is then (4 mA) (1/40,000)=100 nanoamps, resulting in a longevity cost to the device of just over a week.
b. Choice of Special Wakeup Character
In an embodiment where a DC balanced coding scheme such as 8b/10b is employed, it is desired to know a priori that the wakeup special character is always going to have one value independent of the running disparity (RD) of the 8b/10b encoding. The first step in achieving this goal is to choose a wakeup preamble from the set of valid special characters that is bit balanced. There are 7 such codes that have exactly 5 ones and 5 zeros. Codes that are bit balanced do not change the running disparity after transmission so that successive transmission would be identical values avoiding the inversion that occurs on non-bit balanced codes. The second step is to determine what the initial running disparity is when the data portion of the DS message is sent. Since this message is predetermined, it is a simple matter to determine the running disparity. The RD has an initial negative value (RD−) and starts with the first byte of the access code. The RD is then computed after each of the 8b/10b conversions. The RD at the start of the data portion is then the RD after the two universal access code bytes, the command byte, and the length byte. The proposal for wakeup special character and universal access codes is to choose two of the 7 bit-balanced valid special characters. The values are chosen as:
The choice of the RD-K28.0 and K28.4 codes are used as the universal access code. After transmission, the RD remains negative. The command byte and length byte are next to be transmitted. The command and length bytes depend on the value of the DS command code (3) and the length. Using a length of 256 bytes (0x100) gives a command byte of 0x31 and a length byte of 0x00 (The least significant two bits of the command are the most significant bits of the length). The 0x31 command byte then becomes the 8b/10b code of D17.1 that is also bit balanced so the RD remains negative. The 0x00 length byte is the 8b/10b code of D0.0 which converts to 1001110100, again this code is bit balanced so the RD remains negative. Now the wakeup special code K29.7 can be transmitted containing the RD-code of 101110 1000 repeatedly since the RD does not change. The CRC can take on its normal value and does not need to be considered here since it does not affect the RD of the data portion. Note that the alignment pattern is the 8b/10b code K28.5 (001111 1010) since it is the comma character.
Although the invention has been described in conjunction with the foregoing specific embodiments, many alternatives, variations, and modifications will be apparent to those of ordinary skill in the art. Such alternatives, variations, and modifications are intended to fall within the scope of the following appended claims.
This application is a continuation of U.S. application Ser. No. 12/102,480, filed Apr. 14, 2008, now issued as U.S. Pat. No. 8,024,043, which is a continuation of U.S. application Ser. No. 11/101,142, filed Apr. 7, 2005, now issued as U.S. Pat. No. 7,359,753, which claims the benefit of U.S. Provisional Application No. 60/560,171, filed on Apr. 7, 2004, under 35 U.S.C. §119(e), which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
3914586 | McIntosh | Oct 1975 | A |
4341982 | Lahti et al. | Jul 1982 | A |
4404972 | Gordon et al. | Sep 1983 | A |
4441498 | Nordling | Apr 1984 | A |
4486739 | Franaszek et al. | Dec 1984 | A |
4519401 | Ko et al. | May 1985 | A |
4539992 | Calfee et al. | Sep 1985 | A |
4542535 | Bates et al. | Sep 1985 | A |
4543954 | Cook et al. | Oct 1985 | A |
4561443 | Hogrefe et al. | Dec 1985 | A |
4562841 | Brockway et al. | Jan 1986 | A |
4592360 | Lesnick | Jun 1986 | A |
4613937 | Batty, Jr. | Sep 1986 | A |
4634294 | Christol et al. | Jan 1987 | A |
4731814 | Becker et al. | Mar 1988 | A |
4799059 | Grindahl et al. | Jan 1989 | A |
4803987 | Calfee et al. | Feb 1989 | A |
4944299 | Silvian | Jul 1990 | A |
4945909 | Fearnot et al. | Aug 1990 | A |
4987897 | Funke | Jan 1991 | A |
5025808 | Hafner | Jun 1991 | A |
5074308 | Sholder et al. | Dec 1991 | A |
5080096 | Hooper et al. | Jan 1992 | A |
5089019 | Grandjean | Feb 1992 | A |
5109853 | Taicher et al. | May 1992 | A |
5113869 | Nappholz et al. | May 1992 | A |
5171977 | Morrison | Dec 1992 | A |
5230003 | Dent et al. | Jul 1993 | A |
5287384 | Avery et al. | Feb 1994 | A |
5292343 | Blanchette et al. | Mar 1994 | A |
5300093 | Koestner et al. | Apr 1994 | A |
5314453 | Jeutter | May 1994 | A |
5342408 | deCoriolis et al. | Aug 1994 | A |
5350411 | Ryan et al. | Sep 1994 | A |
5350412 | Hoegnelid et al. | Sep 1994 | A |
5370666 | Lindberg et al. | Dec 1994 | A |
5394433 | Bantz et al. | Feb 1995 | A |
5404877 | Nolan et al. | Apr 1995 | A |
5466246 | Silvian | Nov 1995 | A |
5476488 | Morgan et al. | Dec 1995 | A |
5486200 | Lindemans | Jan 1996 | A |
5516285 | Yacker et al. | May 1996 | A |
5532708 | Krenz et al. | Jul 1996 | A |
5535752 | Halperin et al. | Jul 1996 | A |
5562713 | Silvian | Oct 1996 | A |
5568510 | Tam | Oct 1996 | A |
5577087 | Furuyu | Nov 1996 | A |
5579876 | Adrian et al. | Dec 1996 | A |
5593430 | Renger | Jan 1997 | A |
5598847 | Renger | Feb 1997 | A |
5603331 | Heemels et al. | Feb 1997 | A |
5617871 | Burrows | Apr 1997 | A |
5630835 | Brownlee | May 1997 | A |
5650759 | Hittman et al. | Jul 1997 | A |
5683432 | Goedeke et al. | Nov 1997 | A |
5694952 | Lidman et al. | Dec 1997 | A |
5697958 | Paul et al. | Dec 1997 | A |
5725559 | Alt et al. | Mar 1998 | A |
5729680 | Belanger et al. | Mar 1998 | A |
5733313 | Barreras, Sr. et al. | Mar 1998 | A |
5737419 | Ganesan | Apr 1998 | A |
5752976 | Duffin et al. | May 1998 | A |
5752977 | Grevious et al. | May 1998 | A |
5759199 | Snell et al. | Jun 1998 | A |
5764699 | Needham et al. | Jun 1998 | A |
5766232 | Grevious et al. | Jun 1998 | A |
5807397 | Barreras | Sep 1998 | A |
5833603 | Kovacs et al. | Nov 1998 | A |
5843139 | Goedeke et al. | Dec 1998 | A |
5861019 | Sun et al. | Jan 1999 | A |
5870391 | Nago | Feb 1999 | A |
5881101 | Furman et al. | Mar 1999 | A |
5887022 | Lee | Mar 1999 | A |
5895485 | Loechel et al. | Apr 1999 | A |
5898397 | Murray | Apr 1999 | A |
5904708 | Goedeke | May 1999 | A |
5919210 | Lurie et al. | Jul 1999 | A |
5940384 | Carney et al. | Aug 1999 | A |
6009350 | Renken | Dec 1999 | A |
6028527 | Soenen et al. | Feb 2000 | A |
6031863 | Jusa et al. | Feb 2000 | A |
6044485 | Dent et al. | Mar 2000 | A |
6083248 | Thompson | Jul 2000 | A |
6088381 | Myers, Jr. | Jul 2000 | A |
6093146 | Filangeri | Jul 2000 | A |
6115583 | Brummer et al. | Sep 2000 | A |
6115634 | Donders et al. | Sep 2000 | A |
6115636 | Ryan | Sep 2000 | A |
6130905 | Wakayama | Oct 2000 | A |
6155208 | Schell et al. | Dec 2000 | A |
6167310 | Grevious | Dec 2000 | A |
6167312 | Goedeke | Dec 2000 | A |
6169925 | Villaseca et al. | Jan 2001 | B1 |
6200265 | Walsh et al. | Mar 2001 | B1 |
6219580 | Faltys et al. | Apr 2001 | B1 |
6223083 | Rosar | Apr 2001 | B1 |
6240317 | Villaseca et al. | May 2001 | B1 |
6249700 | Alt | Jun 2001 | B1 |
6263246 | Goedeke et al. | Jul 2001 | B1 |
6275737 | Mann | Aug 2001 | B1 |
6309350 | VanTassel et al. | Oct 2001 | B1 |
6329920 | Morrison et al. | Dec 2001 | B1 |
6336900 | Alleckson et al. | Jan 2002 | B1 |
6336903 | Bardy | Jan 2002 | B1 |
6381492 | Rockwell et al. | Apr 2002 | B1 |
6385318 | Oishi | May 2002 | B1 |
6388628 | Dettloff et al. | May 2002 | B1 |
6416471 | Kumar et al. | Jul 2002 | B1 |
6424867 | Snell et al. | Jul 2002 | B1 |
6427088 | Bowman, IV et al. | Jul 2002 | B1 |
6434429 | Kraus et al. | Aug 2002 | B1 |
6443891 | Grevious | Sep 2002 | B1 |
6456256 | Amundson et al. | Sep 2002 | B1 |
6456875 | Wilkinson et al. | Sep 2002 | B1 |
6463329 | Goedeke | Oct 2002 | B1 |
6470215 | Kraus et al. | Oct 2002 | B1 |
6471645 | Warkentin | Oct 2002 | B1 |
6472991 | Schulman et al. | Oct 2002 | B1 |
6482154 | Haubrich et al. | Nov 2002 | B1 |
6490487 | Kraus et al. | Dec 2002 | B1 |
6505072 | Linder et al. | Jan 2003 | B1 |
6527729 | Turcott | Mar 2003 | B1 |
6531982 | White et al. | Mar 2003 | B1 |
6535763 | Hiebert et al. | Mar 2003 | B1 |
6535766 | Thompson et al. | Mar 2003 | B1 |
6562000 | Thompson et al. | May 2003 | B2 |
6562001 | Lebel et al. | May 2003 | B2 |
6564104 | Nelson et al. | May 2003 | B2 |
6564105 | Starkweather et al. | May 2003 | B2 |
6574503 | Ferek-Petric | Jun 2003 | B2 |
6574509 | Kraus et al. | Jun 2003 | B1 |
6574510 | Von Arx et al. | Jun 2003 | B2 |
6577900 | Silvian | Jun 2003 | B1 |
6577901 | Thompson | Jun 2003 | B2 |
6582365 | Hines et al. | Jun 2003 | B1 |
6585644 | Lebel et al. | Jul 2003 | B2 |
6600949 | Turcott | Jul 2003 | B1 |
6600952 | Snell et al. | Jul 2003 | B1 |
6602191 | Quy | Aug 2003 | B2 |
6609029 | Mann et al. | Aug 2003 | B1 |
6614406 | Amundson et al. | Sep 2003 | B2 |
6622043 | Kraus et al. | Sep 2003 | B1 |
6622050 | Thompson | Sep 2003 | B2 |
6624786 | Boyle | Sep 2003 | B2 |
6631296 | Parramon et al. | Oct 2003 | B1 |
6648821 | Lebel et al. | Nov 2003 | B2 |
6659948 | Lebel et al. | Dec 2003 | B2 |
6662048 | Balczewski et al. | Dec 2003 | B2 |
6671328 | Poon et al. | Dec 2003 | B1 |
6675045 | Mass et al. | Jan 2004 | B2 |
6687546 | Lebel et al. | Feb 2004 | B2 |
6708065 | Von Arx et al. | Mar 2004 | B2 |
6716165 | Flanders et al. | Apr 2004 | B1 |
6741886 | Yonce | May 2004 | B2 |
6763269 | Cox | Jul 2004 | B2 |
6768730 | Whitehill | Jul 2004 | B1 |
6801807 | Abrahamson | Oct 2004 | B2 |
6804559 | Kraus et al. | Oct 2004 | B1 |
6809701 | Amundson et al. | Oct 2004 | B2 |
6844854 | Johnson et al. | Jan 2005 | B2 |
6868288 | Thompson | Mar 2005 | B2 |
6889081 | Hsu | May 2005 | B2 |
6897788 | Khair et al. | May 2005 | B2 |
6907291 | Snell et al. | Jun 2005 | B1 |
6970735 | Uber, III et al. | Nov 2005 | B2 |
6978181 | Snell | Dec 2005 | B1 |
6985088 | Goetz et al. | Jan 2006 | B2 |
6985773 | Von Arx et al. | Jan 2006 | B2 |
6993393 | Von Arx et al. | Jan 2006 | B2 |
7013178 | Reinke et al. | Mar 2006 | B2 |
7027872 | Thompson | Apr 2006 | B2 |
7047076 | Li et al. | May 2006 | B1 |
7069086 | Von Arx | Jun 2006 | B2 |
7107085 | Doi | Sep 2006 | B2 |
7110823 | Whitehurst et al. | Sep 2006 | B2 |
7155290 | Von et al. | Dec 2006 | B2 |
7177700 | Cox | Feb 2007 | B1 |
7218969 | Vallapureddy et al. | May 2007 | B2 |
7228182 | Healy et al. | Jun 2007 | B2 |
7274642 | Sako et al. | Sep 2007 | B2 |
7280872 | Mosesov et al. | Oct 2007 | B1 |
7289853 | Campbell et al. | Oct 2007 | B1 |
7319903 | Bange et al. | Jan 2008 | B2 |
7324012 | Mann et al. | Jan 2008 | B2 |
7359753 | Bange et al. | Apr 2008 | B2 |
7406349 | Seeberger et al. | Jul 2008 | B2 |
7457669 | Katoozi et al. | Nov 2008 | B2 |
7519430 | Arx et al. | Apr 2009 | B2 |
7539489 | Alexander | May 2009 | B1 |
7539541 | Quiles et al. | May 2009 | B2 |
7573422 | Harvey et al. | Aug 2009 | B2 |
7610065 | Vallapureddy et al. | Oct 2009 | B2 |
7623922 | Bange et al. | Nov 2009 | B2 |
7664553 | Roberts | Feb 2010 | B2 |
7668596 | Von Arx et al. | Feb 2010 | B2 |
7729776 | Von Arx et al. | Jun 2010 | B2 |
7738964 | Von Arx et al. | Jun 2010 | B2 |
7787953 | Vallapureddy et al. | Aug 2010 | B2 |
7860574 | Von Arx et al. | Dec 2010 | B2 |
7881802 | Quiles et al. | Feb 2011 | B2 |
8024043 | Bange et al. | Sep 2011 | B2 |
8046080 | Von Arx et al. | Oct 2011 | B2 |
8055350 | Roberts | Nov 2011 | B2 |
20010012955 | Goedeke et al. | Aug 2001 | A1 |
20010019614 | Madoukh | Sep 2001 | A1 |
20010027331 | Thompson | Oct 2001 | A1 |
20010047125 | Quy | Nov 2001 | A1 |
20020013614 | Thompson | Jan 2002 | A1 |
20020019606 | Lebel et al. | Feb 2002 | A1 |
20020046276 | Coffey et al. | Apr 2002 | A1 |
20020049480 | Lebel et al. | Apr 2002 | A1 |
20020062139 | Ding | May 2002 | A1 |
20020065509 | Lebel et al. | May 2002 | A1 |
20020065539 | Von Arx et al. | May 2002 | A1 |
20020065540 | Lebel et al. | May 2002 | A1 |
20020109621 | Khair et al. | Aug 2002 | A1 |
20020115912 | Muraki et al. | Aug 2002 | A1 |
20020120838 | Abdulkader | Aug 2002 | A1 |
20020123672 | Christophersom et al. | Sep 2002 | A1 |
20020143372 | Snell et al. | Oct 2002 | A1 |
20020147388 | Mass et al. | Oct 2002 | A1 |
20020159545 | Ramesh et al. | Oct 2002 | A1 |
20020173830 | Starkweather et al. | Nov 2002 | A1 |
20020183806 | Abrahamson et al. | Dec 2002 | A1 |
20030018369 | Thompson et al. | Jan 2003 | A1 |
20030028902 | Cubley et al. | Feb 2003 | A1 |
20030041866 | Linberg et al. | Mar 2003 | A1 |
20030050535 | Bowman, IV et al. | Mar 2003 | A1 |
20030065919 | Albert et al. | Apr 2003 | A1 |
20030074036 | Prutchi et al. | Apr 2003 | A1 |
20030083719 | Shankar et al. | May 2003 | A1 |
20030097157 | Wohlgemuth et al. | May 2003 | A1 |
20030114891 | Hiebert et al. | Jun 2003 | A1 |
20030114897 | Von Arx et al. | Jun 2003 | A1 |
20030114898 | Von Arx et al. | Jun 2003 | A1 |
20030135246 | Mass et al. | Jul 2003 | A1 |
20030146835 | Carter | Aug 2003 | A1 |
20030149459 | Von Arx et al. | Aug 2003 | A1 |
20030159048 | Matsumoto et al. | Aug 2003 | A1 |
20030174069 | Goetz et al. | Sep 2003 | A1 |
20030187484 | Davis et al. | Oct 2003 | A1 |
20030216793 | Karlsson et al. | Nov 2003 | A1 |
20030220673 | Snell | Nov 2003 | A1 |
20040009815 | Zotto et al. | Jan 2004 | A1 |
20040030260 | Von Arx | Feb 2004 | A1 |
20040047434 | Waltho | Mar 2004 | A1 |
20040102815 | Balczewski et al. | May 2004 | A1 |
20040106967 | Von Arx et al. | Jun 2004 | A1 |
20040122489 | Mazar et al. | Jun 2004 | A1 |
20040127959 | Amundson et al. | Jul 2004 | A1 |
20040167587 | Thompson | Aug 2004 | A1 |
20040168071 | Silverbrook | Aug 2004 | A1 |
20040176811 | Von Arx et al. | Sep 2004 | A1 |
20040176822 | Thompson et al. | Sep 2004 | A1 |
20040247047 | Dennis et al. | Dec 2004 | A1 |
20040260363 | Arx et al. | Dec 2004 | A1 |
20040263273 | Ahmed | Dec 2004 | A1 |
20050203582 | Healy et al. | Sep 2005 | A1 |
20050204134 | Von Arx et al. | Sep 2005 | A1 |
20050222933 | Wesby | Oct 2005 | A1 |
20050240245 | Bange et al. | Oct 2005 | A1 |
20050245992 | Persen et al. | Nov 2005 | A1 |
20050283208 | Von Arx et al. | Dec 2005 | A1 |
20050283209 | Katoozi et al. | Dec 2005 | A1 |
20050288738 | Bange et al. | Dec 2005 | A1 |
20060025834 | Von Arx et al. | Feb 2006 | A1 |
20060029100 | Dove | Feb 2006 | A1 |
20060030901 | Quiles et al. | Feb 2006 | A1 |
20060030902 | Quiles et al. | Feb 2006 | A1 |
20060030903 | Seeberger et al. | Feb 2006 | A1 |
20060030904 | Quiles | Feb 2006 | A1 |
20060071756 | Steeves | Apr 2006 | A1 |
20060116744 | Von Arx et al. | Jun 2006 | A1 |
20060161222 | Haubrich et al. | Jul 2006 | A1 |
20060161223 | Vallapureddy et al. | Jul 2006 | A1 |
20060194615 | Vallapureddy et al. | Aug 2006 | A1 |
20060195161 | Li et al. | Aug 2006 | A1 |
20060195162 | Arx et al. | Aug 2006 | A1 |
20060247736 | Roberts | Nov 2006 | A1 |
20070049983 | Freeberg | Mar 2007 | A1 |
20070100396 | Freeberg | May 2007 | A1 |
20070118188 | Von Arx et al. | May 2007 | A1 |
20070185550 | Vallapureddy et al. | Aug 2007 | A1 |
20070260293 | Carpenter et al. | Nov 2007 | A1 |
20070282398 | Healy et al. | Dec 2007 | A1 |
20080015655 | Bange et al. | Jan 2008 | A1 |
20080015656 | Bange et al. | Jan 2008 | A1 |
20080114412 | Bange et al. | May 2008 | A1 |
20080215121 | Bange et al. | Sep 2008 | A1 |
20090216298 | Quiles et al. | Aug 2009 | A1 |
20100106224 | Von Arx et al. | Apr 2010 | A1 |
20100114233 | Von Arx et al. | May 2010 | A1 |
20100121414 | Roberts | May 2010 | A1 |
20100152816 | Von Arx et al. | Jun 2010 | A1 |
20110066211 | Von Arx et al. | Mar 2011 | A1 |
Number | Date | Country |
---|---|---|
0168640 | Jan 1986 | EP |
0607638 | Jul 1994 | EP |
1050265 | Nov 2000 | EP |
1062985 | Dec 2000 | EP |
1308184 | May 2003 | EP |
1495783 | Jan 2005 | EP |
08511702 | Dec 1996 | JP |
WO-9500202 | Jan 1995 | WO |
WO-9819400 | May 1998 | WO |
WO-9912302 | Mar 1999 | WO |
WO-03053515 | Jul 2003 | WO |
WO-03053515 | Jul 2003 | WO |
WO-2005099816 | Oct 2005 | WO |
WO-2005099817 | Oct 2005 | WO |
WO-2006020546 | Feb 2006 | WO |
WO-2006020549 | Feb 2006 | WO |
WO-2006116004 | Nov 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20110313491 A1 | Dec 2011 | US |
Number | Date | Country | |
---|---|---|---|
60560171 | Apr 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12102480 | Apr 2008 | US |
Child | 13218672 | US | |
Parent | 11101142 | Apr 2005 | US |
Child | 12102480 | US |